Company / Total Assets
Atea Pharmaceuticals, Inc. Total Assets History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$666.7M
FY2022
5-year range
$666.7M / $863.6M
FY2020-FY2022
Trend
-13.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $864M to $667M over the past 2 years.
Based on SEC 10-K filings.
$667M in FY2022.
Declined from $864M to $667M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, total assets decreased 13.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $666.7M | -13.7% |
| FY2021 | $772.9M | -10.5% |
| FY2020 | $863.6M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026